The US FDA on Thursday approved Teva Pharmaceuticals’ (TEVA) generic version of EpiPen and EpiPen Jr auto-injector for the emergency treatment of
Search Results for: Teva
Teva Pharmaceuticals shares take a tumble despite earnings beat
Teva Pharmaceutical Industries Ltd. (TEVA) beat market estimates on adjusted EPS for Q2 2018 while revenues came in line with expectations. Despite
US generic drug market throttles Teva Pharmaceuticals as revenue slips
Teva Pharmaceuticals Industries Ltd. (TEVA) reported a decrease of 10% in revenues to $5.1 billion for the first quarter of 2018 compared
American Vanguard Corporation (AVD) Q1 2023 Earnings Call Transcript
American Vanguard Corporation (NYSE:AVD) Q1 2023 Earnings Call dated May. 09, 2023 Corporate Participants: Bill Kuser -- Director of Investor Relations Jim
Corcept Therapeutics Incorporated (CORT) Q1 2023 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q1 2023 Earnings Call dated May. 03, 2023 Corporate participants: Atabak Mokari -- Chief Financial Officer Charlie
Corcept Therapeutics Incorporated (CORT) Q4 2022 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2022 Earnings Call dated Feb. 28, 2023. Corporate Participants: Atabak Mokari -- Chief Financial Officer Charles Robb -- Chief Business Officer
Deckers Outdoor Corporation (DECK) Q3 2023 Earnings Call Transcript
Deckers Outdoor Corporation (NYSE: DECK) Q3 2023 earnings call dated Feb. 02, 2023 Corporate Participants: Erinn Kohler -- Vice President, Investor Relations and Corporate
American Vanguard Corporation (AVD) Q3 2022 Earnings Call Transcript
American Vanguard Corporation (NYSE:AVD) Q3 2022 Earnings Call dated Nov. 08, 2022. Corporate Participants: Timothy J. Donnelly -- Chief Administrative Officer Eric Glenn Wintemute -- Chairman
Corcept Therapeutics Incorporated (CORT) Q3 2022 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Atabak Mokari -- CFO Joseph Belanoff -- CEO Sean Maduck -- President of Endocrinology
IPO Alert: Third Harmonic files to go public. Here’s what you need to know
IPO activity has started gaining steam after falling significantly in the first half, in line with the global trend, but it is
Deckers Outdoor Corporation (DECK) Q4 2022 Earnings Call Transcript
Deckers Outdoor Corporation (NYSE: DECK) Q4 2022 earnings call dated May. 19, 2022 Corporate Participants: Erinn Kohler -- Vice President, Investor Relations and Corporate
Corcept Therapeutics Incorporated (CORT) Q4 2021 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q4 2021 earnings call dated Feb. 15, 2022 Corporate Participants: Atabak Mokari -- Chief Financial Officer Charles Robb -- Chief Business
Corcept Therapeutics Incorporated (CORT) Q3 2021 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q3 2021 earnings call dated Nov. 03, 2021 Corporate Participants: Atabak Mokari -- Chief Financial Officer Charles Robb -- Chief Business
Mayne Pharma Group Ltd (MYX) Q4 2021 Earnings Call Transcript
Mayne Pharma Group Ltd (ASX:MYX) Q4 2021 earnings call dated Aug. 26, 2021. Corporate Participants: Scott Richards -- Chief Executive Officer and
Earnings calendar for the week of July 26
After showing weakness at the beginning of the week, benchmark stock indexes made steady gains even as economic recovery gathered steam. On
Deckers Outdoor Corp. (DECK) Q4 2021 Earnings Call Transcript
Deckers Outdoor Corp. (NYSE: DECK) Q4 2021 earnings call dated May. 20, 2021 Corporate Participants: Erinn Kohler -- Vice President, Investor Relations, Corporate Planning, &
Earnings calendar for the week of April 26
Investor sentiment was hit by the government's proposal to levy higher capital gain tax on wealthy individuals, and the market shifted to
Corcept Therapeutics Incorporated (CORT) Q4 2020 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q4 2020 earnings call dated Feb. 08, 2021 Corporate Participants: Charles Robb -- Chief Financial Officer Joseph K. Belanoff -- Chief
Earnings calendar for the week of February 8
With fresh hopes of economic recovery emerging after the Senate moved closer to passing the $1.9 trillion stimulus package, stock futures are
Regeneron Pharmaceuticals, Inc. (REGN) Q4 2020 Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Q4 2020 earnings call dated Feb. 05, 2021 Corporate Participants: Justin Holko — Vice President, Investor Relations Leonard S.
Dr. Reddy’s Laboratories Ltd. (RDY) Q3 2021 Earnings Call Transcript
Dr. Reddy's Laboratories Ltd. (NYSE: RDY) Q3 2021 earnings call dated Jan. 29, 2021 Corporate Participants: Amit Agarwal -- Head of Investor Relations Parag